HAT-SIL-TG-1&AT is a Janus tyrosine kinase (JAK) inhibitor designed to selectively target JAK-STAT signaling pathways in tumor tissues. This hypoxia-activated prodrug exhibits significant antitumor activity by inhibiting cell proliferation in HEL cells and reducing levels of phosphorylated STAT3 and STAT5 under hypoxic conditions. HAT-SIL-TG-1&AT is relevant for researchers investigating the impact of JAK inhibition in cancer therapies and the underlying mechanisms of tumor hypoxia.
HAT-SIL-TG-1&AT is a Janus tyrosine kinase (JAK) inhibitor designed to selectively target JAK-STAT signaling pathways in tumor tissues. This hypoxia-activated prodrug exhibits significant antitumor activity by inhibiting cell proliferation in HEL cells and reducing levels of phosphorylated STAT3 and STAT5 under hypoxic conditions. HAT-SIL-TG-1&AT is relevant for researchers investigating the impact of JAK inhibition in cancer therapies and the underlying mechanisms of tumor hypoxia.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
